Improved adventitial rapamycin therapy for peripheral artery restenosis
Active Project Grant Awarded Last action
- Award ID
- R44HL102998
- Recipient
-
Mercator Medsystems, Inc. UEI KLANRKKPWQT4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,048,720
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 99% complete
- Originally
- Place of performance
- San Leandro, CA 94577, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,000,000 | |
| Amendment | $1,000,000 | |
| Amendment | $1,000,000 | |
| Amendment | $1,000,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,088,602 | |
| Original award | $960,118 |
Quick answers
Who received award R44HL102998?
R44HL102998 was awarded to Mercator Medsystems, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 15, 2010.
How much is award R44HL102998 worth?
$6,048,720 has been obligated on R44HL102998.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award